2,181 to 2,190 of 2,345 Results
Apr 17, 2023 -
Effects of pepO and CppA in S. sanguinis virulence
MS Word - 18.5 KB -
MD5: 91aeee35633222f53eed6ee1faf696e1
Figure 7A |
Apr 17, 2023 -
Effects of pepO and CppA in S. sanguinis virulence
MS Word - 15.3 KB -
MD5: 6789d125c20d87c2b8a0219114d4bfe9
Figure 7B |
Apr 12, 2023 -
Validation files of the brazilian version of ImpRes-Tool
MS Excel Spreadsheet - 26.5 KB -
MD5: 3e9be0c927a9c666073b03866bd710f4
Values attributed by experts to each item in the Brazilian version of ImpRes |
Apr 12, 2023 -
Validation files of the brazilian version of ImpRes-Tool
MS Word - 18.8 KB -
MD5: c598d39fa73757422b8dbac72aa31f4d
Literal transcription of the focus group to evaluate the use of the Brazilian version of ImpRes |
Apr 12, 2023 -
Validation files of the brazilian version of ImpRes-Tool
MS Excel Spreadsheet - 27.0 KB -
MD5: a261d38079b758f4e1f724bbd96b5551
Grades assigned by users of the Brazilian version of ImpRes regarding its usability and usefulness |
Apr 12, 2023 -
Validation files of the brazilian version of ImpRes-Tool
MS Excel Spreadsheet - 29.5 KB -
MD5: 02ee062195a168f5c66c3870722b2a59
Values attributed in the evaluation of conceptual equivalence by the participants of the first round of evaluation of the final version of ImpRes |
Apr 12, 2023 -
Validation files of the brazilian version of ImpRes-Tool
MS Excel Spreadsheet - 26.5 KB -
MD5: 63fc56e2e361fb12d45f1c4c665fc1fd
Values attributed in the evaluation of conceptual equivalence by the participants of the second round of evaluation of the final version of ImpRes |
Apr 12, 2023 -
Percepção da equipe de enfermagem da atenção primária sobre o cuidado em saúde mental da pessoa idosa dependente: um estudo qualitativo
Adobe PDF - 153.7 KB -
MD5: 90f539c6ad739bd7e2cd517ee0f3ec3f
|
Mar 21, 2023 -
Lenalidomide or thalidomide for transplant-ineligible patients with newly diagnosed myeloma multiple? An overview of systematic reviews
Adobe PDF - 103.5 KB -
MD5: 1a62259220bccf5d7d6008b2c29b1314
Search strategy |
Mar 21, 2023 -
Lenalidomide or thalidomide for transplant-ineligible patients with newly diagnosed myeloma multiple? An overview of systematic reviews
Adobe PDF - 122.7 KB -
MD5: d2eec255f181afc0d40544853c11fce5
Reason for exclusion |
